| Literature DB >> 27375611 |
Muhabat A Raji1, Ghada Garaween1, Ralf Ehricht2, Stefan Monecke2, Atef M Shibl3, Abiola Senok4.
Abstract
Limited data exist from the Gulf Cooperation Council states on the prevalence and population dynamics of Staphylococcus aureus colonizing livestock or contaminating retail meat. This study was designed to determine the presence and genetic characteristics of Staphylococcus aureus isolated from raw retail meat sold in Riyadh, Saudi Arabia. Over a period of 9 months, different raw retail meat types were aseptically processed using the double broth enrichment technique, characteristic colonies from chromogenic and mannitol salt agar were further identified using conventional methods. Susceptibility to 9 antibiotics was determined using the disc diffusion technique. Interpretation of inhibition zone was done according to Clinical and Laboratory Standards Institute guidelines. Molecular characterization was carried out using the StaphyType DNA microarray technology. Twenty-five meat samples yielded Staphylococcus aureus isolates. Camel meat had the highest contamination rate with Methicillin resistant Staphylococcus aureus (MRSA) (20%) and Methicillin susceptible Staphylococcus aureus (28%), while poultry meat had the least contamination rate with MRSA (4%). The MRSA isolates were grouped into 4 clonal complexes (CCs) namely CC1-MRSA-IV/SCCfus (n = 2), CC15-MRSA-V/SCCfus (n = 4), CC80-MRSA-IV/PVL+ (n = 5), and CC88-MRSA-IV/PVL+ (n = 2). All CC15-MRSA-V/SCCfus isolates were obtained from camel meat. This is the first study to demonstrate the novel CC15-MRSA-V/SCCfus in retail camel meat. We recommend that surveillance studies should be incorporated in public health and food hygiene programs.Entities:
Keywords: CC15-MRSA; MRSA prevalence; Saudi Arabia; camel meat; retail meat
Year: 2016 PMID: 27375611 PMCID: PMC4899468 DOI: 10.3389/fmicb.2016.00911
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Distribution and source of the MRSA/MSSA isolates.
| CC1-MRSA-IV/SCC | 2 | Beef (1, NMS), poultry (1, RSC) |
| CC15-MRSA-V/SCC | 4 | Camel (4, NMS) |
| CC80-MRSA-IV/PVL+ | 5 | Camel (1,NMS), lamb (3: 2, RSC; 1, NMS), beef (1, NMS) |
| CC88-MRSA-IV/PVL+ | 2 | Beef (1, NMS), lamb (1, NMS) |
| CC5-MSSA | 2 | Poultry (2: 1, NMS; 1, RSC) |
| CC15-MSSA | 1 | Camel (1, NMS) |
| CC88-MSSA/PVL+ | 1 | Poultry (1, NMS) |
| CC101-MSSA | 1 | Camel (1, NMS) |
| CC121-MSSA/PVL+ | 1 | Poultry (1, NMS) |
| CC361-MSSA | 2 | Camel (1, NMS), lamb (1, NMS) |
| ST1156-MSSA | 4 | Camel (4, NMS) |
| 25 | 21 NMS, 4 RSC |
Key: NMS, neighborhood meat shop; RSC, retail supermarket chain.
Prevalence and distribution of MRSA/MSSA among the meat samples.
| Poultry | 29 | 4 (16) | 1 (4) |
| Camel | 24 | 7 (28) | 5 (20) |
| Lamb/mutton | 24 | 1 (4) | 4 (16) |
| Beef | 23 | 0 (0) | 3 (12) |
| 100 | 12 (48) | 13 (52) | |
Number and percentage resistance to tested antibiotics.
| Penicillin | 10 (83.3) | 11 (84.6) |
| Cefoxitin | 0 (0) | 10 (76.9) |
| Ciprofloxacin | 8 (66.7) | 2 (15.4) |
| Erythromycin | 5 (41.7) | 3 (23.1) |
| Clindamycin | 5 (41.7) | 3 (23.1) |
| Trimethoprim- sulfamethoxazole | 0 (0) | 0 (0) |
| Gentamicin | 0 (0) | 1 (7.7) |
| Linezolid | 0 (0) | 0 (0) |
| Rifampin | 0 (0) | 0 (0) |
Inducible resistance to clindamycin;
Intermediate resistance to clindamycin.
Distribution of selected virulence and resistance genes among the .
| CC1-MRSA-IV/SCC | 2 | III | 8 | |||
| CC15-MRSA-V/SCC | 4 | II | 8 | |||
| CC80-MRSA-IV PVL+ | 5 | III | 8 | |||
| CC88-MRSA-IV PVL+ | 2 | III | 8 | |||
| CC5-MSSA | 2 | II | 5 | |||
| CC15-MSSA | 1 | II | 8 | |||
| CC88-MSSA PVL+ | 1 | III | 8 | |||
| CC101-MSSA | 1 | I | 8 | |||
| CC121-MSSA PVL+ | 1 | IV | 8 | |||
| CC361-MSSA | 2 | I | 8 | |||
| ST1156-MSSA | 4 | I | 8 | |||
Key:
implies presence of gene is variable among the isolates, hld, haemolysin delta; hla, haemolysin alpha; hlb, haemolysin beta; hlgA, haemolysin gamma, component A, clfA, clumping factor A; clfB, clumping factor B; lukD, leukocidin D component; lukF, haemolysin gamma/leukocidin, component B; lukS, haemolysin gamma/leukocidin, component C; lukE, leukocidin E component; lukX, leukocidin/haemolysin toxin family protein; lukY, leukocidin/haemolysin toxin family protein; entA, B,G, H, I, K, M, N, O, Q, U, enterotoxin A, B, G, H, I, K, M, N, O, Q, U; lukS-PV, Panton Valentine leukocidin S component; lukF-PV, haemolysin gamma/leukocidin component B; fib, fibrinogen binding protein; blaZ, beta-lactamase; blaI, beta lactamase repressor; blaR, beta-lactamase regulatory protein; fosB, metallothiol transferase; ermC, erythromycin/clindamycin resistance; tetK, tetracycline-resistance; mecA, alternate penicillin binding protein 2, defining MRSA; aacA-aphD, bifunctional enzyme Aac/Aph, gentamicin resistance; aadD, aminoglycoside adenyltransferase, tobramycin resistance; Q6GD50, hypothetical protein associated with fusidic acid resistance; cna, collagen-binding adhesin; isaB, immunodominant antigen B; sak, staphylokinase; scn, Staphylococcal Complement inhibitor; chp, chemotaxis-inhibiting protein (CHIPS); etD, exfoliative toxin D; edinB, epidermal cell differentiation inhibitor B; linA, Lincosamide nucleotidyl transferase; agr, accessory gene regulator; n, number of isolates belonging to the specified clone.